Because of the importance of retroviral long terminal repeats (LTRs) as determinants of tropism and pathogenic potential, in vitro mutagenesis techniques has been used to alter these elements in the context of an infectious molecular clones of the human immunodeficiency virus (HIV). Starting with a replication-incompetent molecular clone of HIV lacking the two NFkappaB and three Sp1 binding sites present in wild-type LTRS, proviruses containing reconstructed LTRs with individual or combinations of NFkappaB and Sp1 elements were generated and evaluated for their capacity to produce virus progeny following transfection-cocultivation. Virus stocks obtained exhibited a continuum of replicative capacities in different human T-cell types depending on which element(s) was present in the LTR. Of particular interest was the emergence of second-site revertants containing changes affecting the TATA box. An efficient system to monitor the cell-to-cell spread of HIV was developed employing chronically infected H9 donor cells. Under appropriate conditions of co-cultivation, the synthesis of unintegrated viral DNA, monitored by Southern blot hybridization, occurred between 2 and 4 hrs. following infection; viral proteins were detected 8 to 12 hrs following co-cultivation and progeny virions were released into the medium by 16 hrs. The use of metabolic inhibitors and/or specific antibodies revealed that the cell-to-cell spread of HIV required: 1) the interaction of gpl20 with the CD4 receptor and 2) reverse transcrption. Light and electron microscopy indicated that cell-cell fusion, occurring within 15 minutes of co-cultivation, mediated the rapid spread of the infection. Unexpectedly, the fusion observed did not appear to involve budding or free virus particles.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000190-13
Application #
3803108
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Lafont, Bernard A P; McGraw, Christopher M; Stukes, Sabriya A et al. (2007) The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species. Immunogenetics 59:211-23
Igarashi, Tatsuhiko; Donau, Olivia K; Imamichi, Hiromi et al. (2007) Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques. J Virol 81:10669-79
Mao, Hanwen; Lafont, Bernard A P; Igarashi, Tatsuhiko et al. (2005) CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype. J Virol 79:14887-98
Mattapallil, Joseph J; Douek, Daniel C; Hill, Brenna et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093-7
Nishimura, Yoshiaki; Brown, Charles R; Mattapallil, Joseph J et al. (2005) Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc Natl Acad Sci U S A 102:8000-5
Lafont, Bernard A P; Buckler-White, Alicia; Plishka, Ron et al. (2004) Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants. Immunogenetics 56:142-54
Willey, Ronald L; Byrum, Russ; Piatak, Michael et al. (2003) Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles. J Virol 77:1163-74
Nishimura, Yoshiaki; Igarashi, Tatsuhiko; Haigwood, Nancy et al. (2002) Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 76:2123-30
Lifson, Jeffrey D; Martin, Malcolm A (2002) One step forwards, one step back. Nature 415:272-3
Cho, M W; Kim, Y B; Lee, M K et al. (2001) Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques. J Virol 75:2224-34

Showing the most recent 10 out of 14 publications